Valuation: West Pharmaceutical Services, Inc.

Market Cap 24.99B 21.86B 20.16B 18.62B 35.33B 2,383B 35.93B 241B 94.6B 1,174B 93.83B 91.78B 4,036B P/E 2026 *
42x
P/E 2027 * 36.8x
Enterprise Value 24.25B 21.21B 19.56B 18.07B 34.28B 2,313B 34.86B 234B 91.79B 1,139B 91.04B 89.06B 3,916B EV / Sales 2026 *
7.28x
EV / Sales 2027 * 6.77x
Free-Float
93.54%
Yield 2026 *
0.25%
Yield 2027 * 0.27%
1 day-1.10%
1 week-3.29%
Current month-1.47%
1 month+7.07%
3 months+37.87%
6 months+28.38%
Current year+28.56%
1 week 349.41
Extreme 349.41
366.42
1 month 321.94
Extreme 321.94
367.66
Current year 223.83
Extreme 223.83
367.66
1 year 206.8
Extreme 206.8
367.66
3 years 187.43
Extreme 187.43
415.73
5 years 187.43
Extreme 187.43
475.35
10 years 70.17
Extreme 70.17
475.35
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Date Insider Type Main position Quantity % Market Cap.
06-30Other

Director

46 0.0001%
05-12Fiscal year

Executive/Senior Manager

1,759 0.0025%
05-04Free

Director

791 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-3.29%+55.70%-5.76% 24.99B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
0.00%-1.01%-5.28%-3.57% 21.05B
+2.06%+1.72%-10.01%-18.17% 20.39B
Average +0.72%-0.75%+2.65%-1.87% 55.37B
Weighted average by Cap. +0.56%-0.83%-5.77%+0.26%

Financials

2026 *2027 *
Net sales 3.33B 2.92B 2.69B 2.48B 4.71B 318B 4.79B 32.13B 12.62B 157B 12.51B 12.24B 538B 3.54B 3.09B 2.85B 2.64B 5B 337B 5.09B 34.1B 13.39B 166B 13.28B 12.99B 571B
Net income 605M 529M 488M 451M 855M 57.68B 869M 5.83B 2.29B 28.41B 2.27B 2.22B 97.68B 686M 600M 553M 511M 969M 65.39B 986M 6.61B 2.6B 32.21B 2.57B 2.52B 111B
Net Debt -742M -649M -598M -553M -1.05B -70.74B -1.07B -7.15B -2.81B -34.85B -2.79B -2.72B -120B -1.03B -898M -829M -765M -1.45B -97.95B -1.48B -9.9B -3.89B -48.25B -3.86B -3.77B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change Volume
10/07/26 US$353.71 -1.10% 446,114
09/07/26 US$357.66 +1.13% 545,481
08/07/26 US$353.68 -0.67% 924,011
07/07/26 US$356.08 -0.44% 758,960
06/07/26 US$357.64 -2.21% 682,879
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
353.71USD
Average target price
365.93USD
Spread / Average Target
+3.45%

Quarterly revenue - Rate of surprise